NIH-funded research NIH-funded research

New ways to make drug-like compounds

Official title: New Methods for the Synthesis of Biologically Active Compounds

Funded at New York University · NIH-11515318 · Data updated 2026-11-12

Scientists are creating new chemical methods to make molecules that could lead to treatments for cancer, malaria, and bacterial infections.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNew York University
NIH-funded
Lab location1 site (New York, United States)
Project startJune 1, 2023
Project endMarch 31, 2028
Funding year2026
Award (this year)$23,312
NIH project number3R35GM148203-04S1
Project IDNIH-11515318 on NIH RePORTER

Who could benefit from this research

Could help

This project does not enroll patients now, but people with cancer, malaria, or bacterial infections could be future candidates for therapies developed from these compounds.

Less likely to help

Patients needing immediate treatment or those with conditions unrelated to infection or cancer are unlikely to receive direct benefit from this basic laboratory research in the near term.

What this research studies

Researchers at New York University will develop new chemical reactions to build cyclic and aromatic peroxides, natural-product motifs with a range of biological effects. They will study how these compounds trigger cell death through ferroptosis and work to improve the potency and metabolic stability of a lead molecule called FINO2. The team will also study acetal substitution chemistry to make synthesis more reliable and scalable. Collaborations with other labs will help identify the biological targets and mechanisms behind these compounds' effects.

Why it matters

Potential benefit: If successful, this work could produce new types of medicines that kill infection-causing organisms or cancer cells by novel mechanisms.

How similar studies have gone: Some related natural-product peroxides (for example artemisinin for malaria) have been successful, but using cyclic peroxides to trigger ferroptosis in cancer is a newer and less-tested approach.

Where this research is happening

  • New York University
    New York, United States
    Active

Researchers

  • Principal investigator: Woerpel, Keith Allen — New York University
  • Study coordinator: Woerpel, Keith Allen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.